Handelsavisen
prelaunch
Companies Healthcare ASIM.SI
AS
ASIM.SI SGX Healthcare Facilities & Services

Asim.Si

$0,03
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
2,9 %
ROE
12,6 %
Net margin
5,7 %
Debt / equity
1,11
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

ASIM.SI operates in the healthcare sector, providing services and equipment within the healthcare facilities and services industry.

Business. ASIM.SI operates in the healthcare sector, providing services and equipment within the healthcare facilities and services industry.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
12,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ASIM.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ASIM.SI. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    ASIM.SI operates in the healthcare sector, providing services and equipment within the healthcare facilities and services industry.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    ASIM.SI's capital structure is characterized by a debt-to-equity ratio of 1.11, indicating a moderate level of leverage. The company holds cash and equivalents of SGD 5,694,450, but its long-term debt of SGD 17,866,220 suggests a net cash position that is negative after subtracting total debt. The liquidity position is assessed as medium, with a current ratio of 2.1, which is a standard measure of short-term liquidity.

    In terms of profitability, ASIM.SI's return on equity (ROE) is 12.61%, and its return on assets (ROA) is 4.69%. These figures suggest that the company is generating a reasonable return on its equity and assets, though the ROA is relatively modest compared to industry benchmarks. The operating margin, calculated as operating income divided by revenue, is 2.92%, which is a key indicator of operational efficiency.

    ASIM.SI's revenue is concentrated in a single segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could pose a concentration risk, as the company's performance is tied to a single business line.

    The company's growth trajectory is reflected in its recent financial performance. The operating cash flow of SGD 3,878,580 and free cash flow of SGD 2,135,670 indicate positive cash generation, which is essential for sustaining operations and funding growth initiatives. The capital expenditure of SGD -2,676,050 suggests that the company is investing in its operations, which could support future growth.

    Risk factors for ASIM.SI include a medium liquidity risk, primarily due to its debt structure and the potential for dilution, which is currently assessed as low. The company's risk assessment highlights the need to monitor its liquidity position, as the net cash position is negative after subtracting total debt. The dilution potential is low, and no significant adjustments have been applied to the valuation metrics.

    Recent events and filings for ASIM.SI include the latest actual EPS of SGD 0.00 and the latest actual revenue of SGD 12,256,000. These figures provide insight into the company's recent performance and are used by analysts to form their estimates.

    Key takeaways
    • ASIM.SI has a moderate debt-to-equity ratio of 1.11, indicating a balanced capital structure.
    • The company's ROE of 12.61% and ROA of 4.69% suggest reasonable profitability.
    • ASIM.SI's revenue is concentrated in a single segment, which could pose a concentration risk.
    • The company's liquidity position is medium, with a current ratio of 2.1.
    • ASIM.SI's recent operating and free cash flows are positive, indicating strong cash generation.
    • The company's risk assessment highlights the need to monitor its liquidity position.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $0,03
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $16.1M
    Net cash
    -$12.2M
    Current ratio
    2.1
    Debt / equity
    1.1
    ROA
    4.7%
    ROE
    12.6%
    Cash conversion
    192.0%
    CapEx / revenue
    -7.6%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin2,9 %Below median
    Net Margin5,8 %Above median
    ROE12,6 %Above median
    Capex / Rev-7,6 %Below median
    D/E1,11Bottom quartile
    Cash Conv1,92Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • ASIM.SI Market data — financials · 2026-05-27
    • AsiaMedic Ltd Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ASIM.SICanonical
    SGX · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage